Publications 2017

  1. Beek van N, Dähnrich C, Johannsen N, Lemcke S, Goletz S, Hübner F, Zenzo di G, Dmochowski M, Drenovska K, Geller S, Horn M, Kowalewski C, Medenica L, Murrell DF, Patsatsi A, Uzun S, Vassileva S, Zillikens D, Schlumberger W, Schmidt E. Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases. J Am Acad Dermatol 76(5): 889-894 (2017).
  2. Berzero G, Hacohen Y, Komorowski L, Scharf M, Dehais C, Leclercq D, Fourchotte V, Buecher B, Honnorat J, Graus F, Delattre JY, Psimaras D. Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies. Neurol Neuroimmunol Neuroinflamm 4(2): e326 (2017).
  3. Blankestijn MA, Otten HG, Suer W, Weimann A, Knol EF, Knulst AC. Specific IgE to peanut 2S albumin Ara  h 7 has a discriminative ability comparable to Ara h 2 and 6. Clin Exp Allergy doi: 10.1111/cea.13030 [Epub] (2017).
  4. Chen H, Chen S, Lu J, Wang X, Li J, Li L, Fu J, Scheper T, Meyer W, Peng HY, Liu W. Multiparametric detection of antibodies against different EBV antigens to predict risk for nasopharyngeal carcinoma in a high-risk population of China. Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-17-0035 [Epub] (2017).
  5. Chen J, Zheng Q, Hammers CM, Ellebrecht CT, Mukherjee EM, Tang HY, Lin C, Yuan H, Pan M, Langenhan J, Komorowski L, Siegel DL, Payne AS, Stanley JR. Proteomic analysis of pemphigus autoantibodies indicates a larger, more divers and more dynamic repertoire than determined by B cell genetics. Cell Rep 18(1): 237-247 (2017).
  6. Dammermann W, Polywka S, Dettmann I, Mindorf S, Komorowski L, Wehmeyer M, Schulze Zur Wiesch J, Stöcker W, Lüth S. Autoantibodies against „rods an rings“-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a „real life“ cohort. Med Microbiol Immunol doi: 10.1007/s00430-017-0516-z [Epub] (2017).
  7. De Schaepdryver M, Jeromin A, Gille B, Claeys KG, Herbst V, Brix B, Van Damme P, Poesen K. Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2017-316605 [Epub] (2017).
  8. Edmondson DG, Prabhakaran S, Norris SJ, Ullmann AJ, Piesman J, Dolan M, Probst C, Radzimski C, Stöcker W, Komorowski L. Enhanced protective immunogenicity of homodimeric Borrelia burgdorferi Outer Surface Protein C. Clin Vaccine Immunol 24(1)  19 e00306-16 (2017).
  9. Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Rigopoulou EI, Scheper T, Daponte A, Meyer W, Sakkas LI, Hadjigeorgiou G, Bogdanos DP. Immune response against Helicobacter pylori-specific antigens differentiates relapsing remitting from secondary progressive multiple sclerosis. Sci Rep 7(1):7929 (2017).
  10. Ernst D, Weiberg D, Baerlecken NT, Schlumberger W, Daehnrich C, Schmidt RE, Bengel FM, Derlin T, Witte T. Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on 18F-fluorodeoxyglucose positron emission tomography. Artherosclerosis 259:12-19 (2017).
  11. Finke C, Prüss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Münte T, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T. Evalutation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich glioma-inactivated 1 antibodies. JAMA Neurol 74(1):50-59 (2017).
  12. Flechsig A, Rose T, Barkhudarova F, Strauss R, Klotsche J, Dähnrich C, Schlumberger W, Enghard P, Burmester GR, Hiepe F, Biesen R. What is the clinical significance of anti-Sm antibodies in systemic lupus erythamtosus? A comparison with anti-dsDNA antibodies and C3. Clin Exp Rheumatol 35(4): 598-606 (2017).
  13. Florey J, Viall A, Streu S, DiMuro V, Riddle A, Kirk J, Perazotti L, Affeldt K, Wagner R, Vaden S, Harris T, Allenspach K. Use of a granulocyte immunofluorescence assay designed for humans for detection of antineutrophil cytoplasmic antibodies in dogs with chronic enteropathies. J Vet Intern Med 31(4): 1062-1066 (2017).
  14. Frey CF, Marreros N, Renneker S, Schmidt L, Sager H, Hentrich B, Milesi S, Gottstein B. Dogs as victims of their own worms: Serodiagnosis of canine alveolar echinococcosis. Parasit Vectors 10(1): 422 (2017).
  15. Hahn S, Trendelenburg G, Scharf M, Denno Y, Brakopp S, Teegen B, Probst C, Wandinger KP, Buttmann M, Haarmann A, Szabados F, Vom Dahl M, Kümpfel T, Eichhorn P, Gold H, Paul F, Jarius S, Melzer N, Stöcker W, Komorowski L. Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis. J Neuroinflammation 14(1): 123 (2017).
  16. Höltje M, Mertens R, Schou MB, Saether SG, Kochova E, Jarius S, Prüss H, Komorowski L, Probst C, Paul F, Bellmann-Strobl J, Gitler D, Benfenati F, Piepgras J, Ahnert-Hilger G, Ruprecht K. Synapsin-antibodies in psychiatric and neurological disorders: prevalence and clinical findings. Brain Behav Immun doi: 10.1016/j.bbi.2017.07.011. [Epub] (2017).
  17. Honorat JA, Komorowski L, Josephs KA, Fechner K, St Loui EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A. IgLON5 antibody: neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm 4(5):e385 (2017).
  18. Hormann W, Hahn M, Gerlach S, Hochstrate N, Affeldt K, Giesen J, Fechner K, Damoiseaux J. Performance analysis of automated evaluation of Crithidia luciliae-based indirect immunofluorescence tests in a routine setting – strengths and weaknesses. Clin Chem Lab Med doi 10.1515/cclm-2017-0326 [Epub] (2017).
  19. Hoxha E, Beck LH Jr, Wiech T, Tomas NM, Probst C, Mindorf S, Meyer-Schwesinger C, Zahner G, Stahl PR, Schöpper R, Panzer U, Harendza S, Helmchen U, Salant DJ, Stahl RA. An indirect immunofluorescence method facilitates detection of Thrombonspondin Type 1 Domain-Containing 7A-specific antibodies in membranous nephropathy. J Am Soc Nephrol 28(2): 520-531 (2017).
  20. Jendrek ST, Gotthardt D, Nitzsche T, Widmann L, Korf T, Michaels MA, Weiss KH, Liaskou E, Versterhus M, Karlsen TH, Mindorf S, Schemmer P, Bär F, Teegen B, Schröder T, Ehlers M, Hammers CM, Komorowski L, Lehnert H, Fellermann K, Derer S, Hov JR, Sina C. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Gut 66(1):137-144 (2017).
  21. Lang B, Makuch M, Moloney T, Dettman I, Mindorf S, Probst C, Stoecker W, Buckley C, Newton C, Leite M, Maddison P, Komorowski L, Adcock J, Vincent A, Waters P, Irani S. Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry 88(4): 353-361 (2017).
  22. Liaskos C, Marou E, Simopoulou T, Barmakoudi M, Efthymiou G, Scheper T, Meyer W, Bogdanos DP, Sakkas LI. Disease-related autoantibody profile in patients with systemic sclerosis. Autoimmunity 50(7): 414-421 (2017).
  23. Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, Komorowski L, Luo J, Cabral-Marques O, Hammers CM, Lindstrom JM, Lamprecht P, Fischer A, Riemekasten G, Tersteeg C, Sondermann P, Rapoport B, Wandinger KP, Probst C, El Beidag A, Schmidt E, Verkman A, Manz RA, Nimmerjahn F. Mechanisms of autoantibody-induced pathology. Front Immunol 8:603 (2017).
  24. Mantere O, Saarela M, Kieseppä T, Raij T, Mäntylä T, Lindgren M, Rikandi E, Stoecker W, Teegen B, Suvisaari J. Anti-neuronal antibodies in patients with early psychosis. Schizophr Res doi: 10.1016/j.schres.2017.04.027. [Epub] (2017).
  25. Marou E, Liaskos C, Efthymiou G, Dardiotis E, Daponte A, Scheper T, Meyer W, Hadjigeorgiou G, Bogdanos DP, Sakkas LI. Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis. Clin Exp Rheumatol PMID: 28240591 [Epub] (2017).
  26. Marou E, Liaskos C, Simopoulou T, Efthymiou G, Dardiotis E, Katsiari C, Scheper T, Meyer W, Hadjigeorgiou G, Bogdanos DP, Sakkas LI. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis. Clin Rheumatol 36(4): 863-869 (2017).
  27. Mindorf S, Dettmann I, Krueger S, Fuhrmann T, Rentzsch K, Probst C, Komorowski L, Fechner K, van Beek N, Lemcke S, Sardy M, Bienert C, Benoit S, Zillikens D, Pas HH, Jonkmann M, Stoecker W, Schmidt E; International Autoimmune Bullous Diseases Study Group. Routine detection of serum anti-desmocollin autoantibodies is only useful in patients with atypical pemphigus. Exp Dermatol doi: 10.1111/exd.13409. [Epub] (2017).
  28. Munyua P, Corman VM, Bitek A, Osoro E, Meyer B, Müller MA; Lattwein E, Thumbi SM, Murithi R, Widdowson MA, Drosten C, Njenga MK. No serological evidence of Middle East Respiratory Syndrome Coronavirus infection among camel farmers exposed to highly seropositive camel herds: a household linked study, Kenya, 2013. Am J Trop Med Hyg 96(6): 1318-1324 (2017).
  29. Neumann K, Cavalar M, Rody A, Beyer DA. HPV-Infektionen. Diagnostik und Impfung. Tumor Diag u Ther 38: 1-5 (2017).
  30. Popkirov S, Ayzenberg I, Hahn S, Bauer J, Denno Y, Rieckhoff N, Radzimski C, Hans VH, Berg S, Roghmann F, Noldus J, Bien CG, Skodda S, Wellmer J, Stöcker W, Krogias C, Gold R, Schlegel U, Probst C, Komorowski L, Miske R, Kleiter I. Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis. Acta Neuropathol Commun 5(1):40.
  31. Rommel FR, Miske R, Stöcker W, Arneth B, Neubauer BA, Hahn A. Chorea minor associated with anti-neurochondrin autoantibodies. Neuropediatrics doi: 10.1055/s-0037-1606371 [Epub] (2017).
  32. Saether SG, Schou M, Stoecker W, Teegen B, Borowski K, Vaaler A, Kondziella D, Reitan SK. Onconeural antibodies in acute psychiatric inpatient care. J Neuropsychiatry Clin Neurosci 29(1): 74-76 (2017).
  33. Satanovskij R, Bader A, Block M, Herbst V, Schlumberger W, Haack T, Nockher WA, Heemann U, Renders L, Schmaderer C, Angermann S, Wen M, Meitinger T, Scherberich J, Steubl D. A new missense mutation in UMOD gene leads to severely reduced serum uromodulin concentrations – a tool for the diagnosis of uromodulin-associated kidney disease. Clin Biochem 50(3): 155-158 (2017).
  34. Scherberich J, Gruber R, Nockher WA, Christensen EI, Schmitt H, Herbst V, Block M, Kaden J, Schlumberger W. Serum uromodulin – a marker of kidney function and renal parenchymal integrity. Nephrol Dial Transplant doi: 10.1093/ndt/gfw422. [Epub] (2017).
  35. Steubl D, Block M, Herbst V, Schlumberger W, Nockher A, Angermann S, Schmaderer C, Heemann U, Renders L, Scherberich J. Serum uromodulin predicts graft failure in renal transplant recipients. Biomarkers 22(2): 171-177 (2017).
  36. Vanderstichele H, Demeyer L, Janelidze S, Coart E, Stoops E, Mauroo K, Herbst V, Francois C, Hansson O. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40). Alzheimers Res Ther 9(1):40 (2017).
  37. Wang J, Cui Z, Lu J, Probst C, Zhang YM, Wang X, Qu Z, Wang F, Meng LQ, Cheng XY, Liu G, Debiec H, Ronco P, Zhao MH. Circulating antibodies against thrombospondin type-1 domain-containing 7A in Chinese patients with idiopathic membranous nephropathy. Clin J Am Soc Nephrol doi: 10.2215/CJN.01460217 [Epub] (2017).
  38. Willemse E, van Uffelen K, Brix B, Engelborghs S, Vanderstichele H, Teunissen C. How to handle adsorption of cerebospinal fluid amyloid-β (1-42) in laboratory practice? Identifying problematic handlings and resolving the issue by use of the Aβ42/Aβ40 ratio. Alzheimers Dement 13(8): 885-892 (2017).
  1. Chunder R, Linington C, Graus F, Sabater L, Stöcker W, Komorowski L, Probst C. Recombinant cell-based indirect imunofluorescence assay for the detection of IgM anti-HNK-1 paraproteins in polyneuropathy. American Academy of Neurology 69. Annual Meeting, Boston, USA (2017).
  2. Damoiseaux J, Mallet K, van Beers J, Hahn M, Krause C, Hormann W, Fechner K. Performance analysis of automated evaluation of anti-nuclear antibody indirect immunofluorescence tests in a routine setting. 13. Dresden Symposium on Autoantibodies, Dresden, Germany (2017).
  3. Efthymiou G, Liaskos C, marou E, Simopoulou T, Scheper T, Meyer W, Bogdanos DP, Sakkas LI. Antibody responses against human cytomegalovirus antigens in patients with systemic sclerosis. 13. Dresden Symposium on Autoantibodies, Dresden, Germany (2017).
  4. Gkoutzourelas A, Liaskos C, Scheper T, Meyer W, , Bogdanos DP, Sakkas LI. Epitope mapping of anti-Ro52 antibody responses in patients with autoimmune rheumatic diseases reveals differential epitope mapping. 13. Dresden Symposium on Autoantibodies, Dresden, Germany (2017).
  5. Hahn S, Trendelenburg G, Scharf M, Denno Y, Brakopp S, Teegen B, Probst C, Wandinger KP, Buttmann M, Szabados F, Dahl vom M, Kümpfel T, Eichhorn P, Gold HJ, Jarius S, Melzer N, Stöcker W, Komorowski L. Identification of the flotillin-1/2 heretocomplx as a target of autoantibodies in multiple sclerosis. American Academy of Neurology 69. Annual Meeting, Boston, USA (2017).
  6. Herbst V, Brix B, Block M. New automated chemiluminescence immunoassay for CSF beta-amyloid determination. 11. International Conference on Alzheimer’s and Parkinson’s Disease, Vienna, Austria (2017).
  7. Herbst V, Brix B, Vanderstichele HM. A novel colorimetric ELISA for quantification of tau, phosphorylated at threonine 181, in cerebrospinal fluid. Alzheimer`s Association International Conference 2017, London, UK (2017).
  8. Kade S, Strippel C, Teegen B, Miske R, Scharf M, Denno Y, Probst C, Radzimski C, Stöcker W, Melzer N, Komorowski L. Identification of the CNTN1/CASPR complex as the target of autoantibodies in a patient with chronic inflammatory demyelinating polyneuropathy. American Academy of Neurology 69. Annual Meeting, Boston, USA (2017).
  9. Oesterreich B, Klemens O, Fraune J, Streit A, Warnecke JM, Steinhagen K. Novel ELISA using antigens from Strongyloides papillosus instead of S. ratti exhibit increased serological specificity. 27. ECCMID, Vienna, Austria (2017).
  10. Rudolph S, Kouba M, Sack U, Stöcker W, Conrad K. Anti-DDPX antibody associated encephalitis in a patient with SLE and CVID. 13. Dresden Symposium on Autoantibodies, Dresden, Germany (2017).
  11. Scharf M, Miske R, Kade S, Hahn S, Begemann N, Denno Y, Probst C, Teegen B, Borowski K, Stöcker W, Komorowski L. The role of mass spectrometry in the identification of autoantibodies as targets in neurological autoimmune diseases. 50. Annual Meeting German Society of mass spectrometry, Kiel, Germany (2017).
  12. Scherberich J, Delgado GE, Kleber M, Scharnagl H, Krämer BK, Herbst V, Block M, Christensen EI, Nockher W, Schlumberger W, März W. Serum uromodulin: an early diagnostic and prognostic tissue-specific marker of kidney injury. Symposium Biomarkers of the Cardiorenal axis, DACH-Gesellschaft, Mannheim, Germany (2017).
  13. Steinhagen K, Lattwein E, Fraune J, Schlumberger W, Warnecke J. Absence of specific IgM in week six post symptom onset in a patient with confirmed Zika virus infection. 1. International Conference on Zika Virus, Washington, USA (2017).
  14. Steinhagen K, Sendscheid O, Klemens JM, Fraune J, Schlumberger W. Combined detection of specific IgG and IgM antibodies for a reliable screening for West-Nile virus infections. 33. Clinical Virology Symposium of the American Society for Microbiology, Savannah, USA (2017).
  15. Vanderstichele H, Chassaing E, Demeyer L, Pannee J, Herbst V, Bodnar-Wachtel M, Stoops E, Hansson O, Blennow K. Differences in analytical selectivity of β-amyloid (1-42) immunoassays explains discordant results in study comparisons. Alzheimer's Association International Conference 2017, London, UK (2017).
  16. Waters P, Komorowski L, Brilot F, Pittock SJ, Probst C, Probst M, Reindl M. Multicentre MOG antibody detection. 13. Dresden Symposium on Autoantibodies, Dresden, Germany (2017).
  17. Wilhelm N, Klemens JM, Steinhagen K, Schlumberger W. New diagnostic markers for differentiation of acute and convalescent human cytomegalovirus infections. 27. ECCMID, Vienna, Austria (2017).
  1. Brix B, Vanderstichele HM, Janelidze S, Demeyer L, Coart E, Stoops E, Hansson O. The CSF Aβ(1-42)/Aβ(1-40) ratio improves the clinical utility of Aβ(1-42) by its impact at analytical and clinical level. Alzheimer`s Association International Conference 2017, London, UK (2017).
  2. Fechner K. Efficient IFA workflows from sample identification to final report of autoantibody analyses. 13. Dresden Symposium on Autoantibodies, Dresden, Germany (2017).
  3. Gille B, Schaeverbeke J, Vanderstichele HM, Adamczuk K, Demeyer L, Francois C, Herbst V, Brix B, Tournoy J, Vandenberghe R, Poesen K. Synaptic markers in liquor inversely correlate with grey matter volume in cognitively healthy individuals. Alzheimer`s Association International Conference 2017, London, UK (2017).
  4. Grypiotis P. Ultrafast EUROPattern: A new era in automatic IFA microscopy. 13. Dresden Symposium on Autoantibodies, Dresden, Germany (2017).
  5. Jurianz E, Schulz S, Reckert S, Liebhaber A, Keyßer G, Schäfer C, Altermann W, Schlaf G, Schlumberger W, Schaller H-G, Reichert S. Parodontitis, HLA-Allele und Autoantikörper gegen citrullinierte Peptide bei Patienten mit Rheumatoider Arthritis. DG PARO-Jahrestagung, Dresden, Germany (2017).
  6. Meyer W. Laboratory diagnostics of autoimmune myopathies. 13. Dresden Symposium on Autoantibodies, Dresden, Germany (2017).
  7. Mindorf S, Dettmann IM, Krüger S, Rentzsch K, Fuhrmann T, Probst C, Komorowski L, Fechner K, Beek van N, Lemcke S, Sárdy M, Bengert C, Benoit S, Hashimoto T, Zillikens D, Pas HH, Jonkman M, Stöcker W, Schmidt E, International Autoimmune Bullous Disease Study Group. Die diagnostische Relevanz von Anti-Desmocollin Antikörpern bei Pemphiguserkrankungen. 49. DDG-Tagung, Berlin, Germany (2017).
  8. Miske R, Scharf M, Borchers C, Denno Y, Teegen B, Rochow N, Probst C, Stöcker W, Kermer P, Komorowski L. Identification of RGS8 as an autoantibody target in paraneoplastic cerebellar syndrome. XXVI AINI Congress/16. ESNI Course, Venice, Italy (2017).
  9. Steinhagen K, Wilhelm N, Schmidt-CHanasit J, Emmerich P, Huzly D, Lattwein D, Fraune J, Schlumberger W, Warnecke J. Anti-Zika virus IgA may indicate an acute infection in anti-Zika virus IgM-negative patients. 1. International Conference on Zika Virus, Washington, USA (2017).
  10. Stoecker W. Techniques in autoimmune diagnostics. Avancées majeures en auto-immunité, Groupe d’Ètude de l’Auto-Immunité Marocain. Casablanca, Morocco (2017).
  11. Stoecker W. Antibodies against neuronal antigens. Avancées majeures en auto-immunité, Groupe d’Ètude de l’Auto-Immunité Marocain. Casablanca, Morocco (2017).
  12. Stoecker W. Prevalence of 39 anti-neural autoantibodies in 40.000 analysed samples (2016). 13. Dresden Symposium on Autoantibodies, Dresden, Germany (2017).
  13. Verbeek M, Neville D, van Gerresheim E, Vanderstichele HM, Brix B, Steiger A, Dresler M. Association between nocturnal amyloid beta fluctuations and sleep. Alzheimer`s Association International Conference 2017, London, UK (2017).
  14. Zeng Z, Miske R, Scharf M, Denno Y, Probst C, Stöcker W, Komorowski L. Characterization of cryptic antinuclear autoantibody target antigens. 13. Dresden Symposium on Autoantibodies, Dresden, Germany (2017).
  1. Buschtez M, Rottmann N, Kayser K. Gewebekassette. Chinese and European patent application CN106560409A (filed 2016) and EP 3150278 (filed 2015).
  2. Feirer C, Roznowicz F, Paul M, Bernitt E. Optical scanning arrangement and method. European patent application (filed 2017).
  3. Kemsies D, Schröder D, Nevermann S. Incubation tray. Hongkong patent application 1219307A (filed 2016).
  4. Pannhoff H, Feirer C. Calibration standard for a device for image-based representation of biological material. Japanese and Brazilian patent application 2017-502280 (filed 2014) and BR112016013866-0 (filed 2014).
  5. Scheper T, Meyer W. Diagnostic immunodetection of autoantibodies to gangliosides. European patent application EP 3124972 (filed 2015).
  6. Scheper T, Meyer W, Schmidt L, Gottstein B, Spiliotis M. A novel assay for the diagnosis of helminth infections. European and Chinese patent application EP3156798 (filed 2015) and CN106596964A (filed 2016).
  7. Steinhagen K, Deerber A, Lattwein E, Radzimski C, Böthfür J. An immunoassay for the diagnosis of viral infections. International patent application WO2017/144174 (filed 2017).
  8. Stöcker W. Verbesserte Vorrichtung und Verfahren für Reaktionen zwischen einer festen und einer flüssigen Phase.  Japanese and Hongkong patent application 2017-500585A (filed 2014) and 1223152A (filed 2014).
  9. Stöcker W, Kowtun A, Huth B, Koschinat L, Richter L. Verfahren und Vorrichtung zur Überführung von Flüssigkeiten. Chinese and US patent application CN106457248A (filed 2015) and US2017/0128945A1 (filed 2015).
  10. Stöcker W, Kowtun A, Huth B, Koschinat L, Richter L. Verfahren und Vorrichtung zur Überführung von Flüssigkeiten. Chinese and US patent application CN106824312A (filed 2015) and US2017/0176303A1 (filed 2016).
  11. Stöcker W, Kowtun A, Huth B, Koschinat L, Richter L. Verfahren und Vorrischtung zur Überführung von Flüssigkeiten. European patent application EP 3160646 (filed 2015).
  12. Suer W, Rohwer S, Denno Y. A novel macadamia allergen. Chinese, European, Singapurean, Taiwanese and US patent application CN106995491A (filed 2016), EP 3196209 (filed 2016), 10201609851R (filed 2016), TW 201726710 A (filed 2017) and US-2017-0209566-A1 (filed 2017).
  13. Wessel S. Use of a pressure sensor in life science applications. European patent application EP 3165931 (filed 2015).